Mark Altmeyer, founder and CEO of Arvelle Therapeutics, speaks with BioBoss host John Simboli. Hear Mark’s thoughts about leadership and how Arvelle is working to bring new solutions to people living with epilepsy and CNS disorders.

BioBoss

#28 - Mark Altmeyer: Founder and CEO of Arvelle Therapeutics

BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen each month as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you make change? Why should I care?" to a new biopharma executive and hear insights on this rapidly changing field.

About

BioBoss